Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sorich

Showing results (51-60 of 216) with videos related to

Pageof 22
Sort By:
The Oncologist|April 29, 2021
Patient-Reported Outcomes Predict Progression-Free Survival of Patients with Advanced Breast Cancer Treated with AbemaciclibSarah Badaoui, Ganessan Kichenadasse, Andrew Rowland, et al.
Clinical and Experimental Pharmacology & Physiology|December 18, 2003
In silico insights: chemical and structural characteristics associated with uridine diphosphate-glucuronosyltransferase substrate selectivityP A Smith, M J Sorich, R A McKinnon, et al.
Pharmacogenetics|November 20, 2002
Pharmacophore and quantitative structure activity relationship modelling of UDP-glucuronosyltransferase 1A1 (UGT1A1) substratesMichael J Sorich, Paul A Smith, Ross A McKinnon, et al.
Frontiers in Pharmacology|January 14, 2017
Optimized Cocktail Phenotyping Study Protocol Using Physiological Based Pharmacokinetic Modeling and <i>In silico</i> Assessment of Metabolic Drug-Drug Interactions Involving ModafinilAngela Rowland, Arduino A Mangoni, Ashley Hopkins, et al.
British Journal of Clinical Pharmacology|July 30, 2024
Establishing the capacity to monitor proteins relevant to the study of drug exposure and response using liver-derived extracellular vesiclesLauren A Newman, Zivile Useckaite, Ting Wu, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 13, 2023
Analysis of Extracellular Vesicle and Contaminant Markers in Blood Derivatives Using Multiple Reaction MonitoringLauren A Newman, Zivile Useckaite, Ting Wu, et al.
Journal of Chemical Information and Modeling|September 26, 2006
Systematic statistical comparison of comparative molecular similarity indices analysis molecular fields for computer-aided lead optimizationMafalda M Dias, Ruchi R Mittal, Ross A McKinnon, et al.
The Pharmacogenomics Journal|September 11, 2013
Exploration of the perceptions, barriers and drivers of pharmacogenomics practice among hospital pharmacists in Adelaide, South AustraliaM M Dias, H M Ward, M J Sorich, et al.
International Journal of Cancer|December 22, 2015
Angiotensin system inhibitors and survival in patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A pooled secondary analysis of clinical trialsMichael J Sorich, Ganessan Kichenadasse, Andrew Rowland, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 21, 2013
Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosisMichael D Wiese, Andrew Rowland, Thomas M Polasek, et al.
Pageof 22

Showing results (51-60 of 216) with videos related to

Sort By:
Pageof 22
The Oncologist|April 29, 2021
Patient-Reported Outcomes Predict Progression-Free Survival of Patients with Advanced Breast Cancer Treated with AbemaciclibSarah Badaoui, Ganessan Kichenadasse, Andrew Rowland, et al.
Clinical and Experimental Pharmacology & Physiology|December 18, 2003
In silico insights: chemical and structural characteristics associated with uridine diphosphate-glucuronosyltransferase substrate selectivityP A Smith, M J Sorich, R A McKinnon, et al.
Pharmacogenetics|November 20, 2002
Pharmacophore and quantitative structure activity relationship modelling of UDP-glucuronosyltransferase 1A1 (UGT1A1) substratesMichael J Sorich, Paul A Smith, Ross A McKinnon, et al.
Frontiers in Pharmacology|January 14, 2017
Optimized Cocktail Phenotyping Study Protocol Using Physiological Based Pharmacokinetic Modeling and <i>In silico</i> Assessment of Metabolic Drug-Drug Interactions Involving ModafinilAngela Rowland, Arduino A Mangoni, Ashley Hopkins, et al.
British Journal of Clinical Pharmacology|July 30, 2024
Establishing the capacity to monitor proteins relevant to the study of drug exposure and response using liver-derived extracellular vesiclesLauren A Newman, Zivile Useckaite, Ting Wu, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 13, 2023
Analysis of Extracellular Vesicle and Contaminant Markers in Blood Derivatives Using Multiple Reaction MonitoringLauren A Newman, Zivile Useckaite, Ting Wu, et al.
Journal of Chemical Information and Modeling|September 26, 2006
Systematic statistical comparison of comparative molecular similarity indices analysis molecular fields for computer-aided lead optimizationMafalda M Dias, Ruchi R Mittal, Ross A McKinnon, et al.
The Pharmacogenomics Journal|September 11, 2013
Exploration of the perceptions, barriers and drivers of pharmacogenomics practice among hospital pharmacists in Adelaide, South AustraliaM M Dias, H M Ward, M J Sorich, et al.
International Journal of Cancer|December 22, 2015
Angiotensin system inhibitors and survival in patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A pooled secondary analysis of clinical trialsMichael J Sorich, Ganessan Kichenadasse, Andrew Rowland, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 21, 2013
Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosisMichael D Wiese, Andrew Rowland, Thomas M Polasek, et al.
Pageof 22